Tumor retarding (1,2-diphenyl-ethylenediamine)-platinum(II)-complexes
    1.
    发明授权
    Tumor retarding (1,2-diphenyl-ethylenediamine)-platinum(II)-complexes 失效
    抗肿瘤剂(1,2-二苯基 - 乙二胺) - 铂(II) - 复合物

    公开(公告)号:US4730068A

    公开(公告)日:1988-03-08

    申请号:US831913

    申请日:1986-02-21

    摘要: There are disclosed antitumor active 1,2-diphenyl-ethylenediamine)-platinum(II)-complex of the general formula ##STR1## wherein R.sub.7 is hydrogen or C.sub.1 -C.sub.6 -alkyl and R.sub.2 is either (1) a halogen atom and the groups R.sub.1, R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are the same or different and are hydrogen, halogen, trihalomethyl, C.sub.1 -C.sub.6 -alkyl, hydrogen C.sub.1 -C.sub.6 -alkoxy, a C.sub.2 -C.sub.6 -alkanoyloxy or a halo or C.sub.1 -C.sub.4 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group, or R.sub.2 is (2) a hydroxy group, a C.sub.1 -C.sub.6 -alkoxy group, a C.sub.2 -C.sub.6 -alkanoyloxy group in the 4-position or a halo or C.sub.1 -C.sub.4 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group and if R.sub.2 is (2) then the groups R.sub.1 and R.sub.3 which are the same or differnt are in the 2 and 6 positions of the phenyl group and are halogen, trihalomethyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, a C.sub.1 -C.sub.6 -alkoxy, C.sub.2 -C.sub.6 -alklanoyloxy group or a halo or C.sub.1 -C.sub.5 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group, with the proviso that R.sub.1 can also be hydrogen and the groups R.sub.4, R.sub.5, and R.sub.6 are the same or different and are hydrogen, halogen, trihalomethyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy, a C.sub.2 -C.sub.6 -alkanoyloxy group or a halo or C.sub.1 -C.sub.4 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group and X is the equivalent of a physiologically compatible anion and process of their production.

    摘要翻译: 公开了具有通式“IMAGE”I的抗肿瘤活性的1,2-二苯基 - 乙二胺) - 铂(II) - 复合物,其中R 7是氢或C 1 -C 6 - 烷基,R 2是(1)卤素原子, 基团R 1,R 3,R 4,R 5和R 6相同或不同,为氢,卤素,三卤甲基,C 1 -C 6 - 烷基,C 1 -C 6 - 烷氧基,C 2 -C 6 - 烷酰氧基或卤素或C 1 -C 4 - 烷磺酰氧基取代的C 2 -C 6 - 烷酰氧基,或R 2为(2)羟基,C 1 -C 6 - 烷氧基,C 4 -C 6 - 烷酰氧基或卤素或C 1 -C 4 - 烷磺酰氧取代 C 2 -C 6 - 烷酰氧基,如果R 2为(2),则相同或不同的基团R 1和R 3为苯基的2和6位,为卤素,三卤代甲基,C 1 -C 6烷基,羟基, C 1 -C 6 - 烷氧基,C 2 -C 6 - 烷酰氧基或卤素或C 1 -C 5 - 烷磺酰氧基取代的C 2 -C 6 - 烷酰氧基,条件是R 1也可以是氢,基团R 4,R 5和R 6是 相同或不同的 氢,卤素,三卤代甲基,C 1 -C 6 - 烷基,羟基,C 1 -C 6 - 烷氧基,C 2 -C 6 - 烷酰氧基或卤素或C 1 -C 4 - 烷磺酰氧基取代的C 2 -C 6 - 烷酰氧基,X等同于 生理上相容的阴离子及其生产方法。

    (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds
    2.
    发明授权
    (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds 失效
    (1,2-二苯基) - 乙二胺) - 铂(II)络合物

    公开(公告)号:US4598091A

    公开(公告)日:1986-07-01

    申请号:US580238

    申请日:1984-02-15

    CPC分类号: C07F15/0093

    摘要: There are prepared antitumor active (1,2-diphenyl-ethylenediamine)-platinum (II) complex compounds of the formula ##STR1## where the groups R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are the same or different and are hydrogen, hydroxy groups, C.sub.1 -C.sub.6 -alkoxy groups, C.sub.2 -C.sub.6 -alkanoyloxy groups which optionally are substituted by halogen atoms or C.sub.1 -C.sub.4 -alkanesulfonyloxy groups or C.sub.3 -C.sub.6 -alkenoyloxy groups and at least one of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 is not hydrogen and X is the equivalent of a physiologically compatible or pharmaceutically acceptable anion.

    摘要翻译: 制备式Ⅰ的抗肿瘤活性(1,2-二苯基 - 乙二胺) - 铂(II)配合物,其中基团R 1,R 2,R 3和R 4相同或不同,为氢,羟基, C 1 -C 6烷氧基,任选被卤素原子或C 1 -C 4烷基磺酰氧基或C 3 -C 6 - 烯酰氧基取代的C 2 -C 6 - 烷酰氧基,R 1,R 2,R 3和R 4中的至少一个不是氢, X相当于生理上相容或药学上可接受的阴离子。

    Diamine-platinum (II) complex compounds
    4.
    发明授权
    Diamine-platinum (II) complex compounds 失效
    二胺 - 铂(II)络合物

    公开(公告)号:US4992553A

    公开(公告)日:1991-02-12

    申请号:US438984

    申请日:1989-11-20

    CPC分类号: C07F15/0093

    摘要: A compound of the general formula: ##STR1## wherein R.sub.1 is hydrogen, a hydroxy group or a C.sub.2 -C.sub.6 alkanoyloxy group, R.sub.2 is hydrogen or a halogen atom, R.sub.3 is hydrogen or a C.sub.1 -C.sub.6 alkyl group, R.sub.4 is a hydroxy group or a C.sub.2 -C.sub.6 alkanoyloxy group, R.sub.5 is hydrogen or a halogen atom and R.sub.6 is hydrogen or a halogen atom, Alk is a C.sub.2 -C.sub.10 alkylene chain where 4 neighboring CH.sub.2 groups may also be replaced by a 1,4-phenylene ring, A-B is the group HN--CH.sub.2 --CH.sub.2 --NH.sub.2, H.sub.2 N--CH.sub.2 --CH--CH.sub.2 --NH.sub.2 or ##STR2## and R.sub.7 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl group or a phenyl radical and X stands for the equivalent of a physiologically acceptable anion. The compound is useful for the treatment of hormone dependent tumors.

    摘要翻译: 一种通式如下的化合物,其中R 1是氢,羟基或C 2 -C 6烷酰氧基,R 2是氢或卤原子,R 3是氢或C 1 -C 6烷基,R 4是羟基 基团或C 2 -C 6烷酰氧基,R 5是氢或卤素原子,R 6是氢或卤素原子,Alk是C 2 -C 10亚烷基链,其中4个相邻的CH 2基也可以被1,4-亚苯基环取代 ,AB是基团HN-CH 2 -CH 2 -NH 2,H 2 N-CH 2 -CH-CH 2 -NH 2或R 7,并且R 7是氢原子,C 1 -C 6烷基或苯基,X表示相当于 生理上可接受的阴离子。 该化合物可用于治疗激素依赖性肿瘤。

    Tumor retarding (1-benzyl-ethylenediamine)-platin (II)-complexes
    7.
    发明授权
    Tumor retarding (1-benzyl-ethylenediamine)-platin (II)-complexes 失效
    肿瘤抑制(1-苄基 - 乙二胺) - 铂(II) - 复合物

    公开(公告)号:US4704464A

    公开(公告)日:1987-11-03

    申请号:US831911

    申请日:1986-02-21

    CPC分类号: C07F15/0093

    摘要: There are described (1-benzylethylenediamine)-platin(II)-complexes of the general formula: ##STR1## wherein the radicals R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are the same or different and are hydrogen, a C.sub.1 -C.sub.6 -alkyl group, a benzyl group, or a phenylethyl group, and B is a thienyl radical, an indolyl radical, an imidazolyl radical, or a phenyl radical substituted by the radicals R.sub.5, R.sub.6, an R.sub.7 which are the same or different and are hydrogen, halogen, trihalomethyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy, phenoxy, benzyloxy, C.sub.1 -C.sub.6 -alkanoyloxy, benzoyloxy, C.sub.1 -C.sub.6 -alkanesulfonyloxy, carboxy, C.sub.1 -C.sub.6 -carbalkoxy, cyano, aminocarboxyl, aminocarbonyl, which contains one or two C.sub.1 -C.sub.6 -alkyl radicals, C.sub.1 -C.sub.6 -alkylcarbonyl, nitro, amino, C.sub.1 -C.sub.6 -alkylamino, di-C.sub.1 -C.sub.6 -alkylamino, (C.sub.1 -C.sub.6 -alkyl).sub.3 N.sup.+, C.sub.1 -C.sub.6 -alkanoylamino, C.sub.1 -C.sub.6 -alkyl-C.sub.1 -C.sub.6 -alkanoylamino, C.sub.1 -C.sub.6 -alkanesulfonylamino, C.sub.1 -C.sub.6 -alkyl-C.sub.1 -C.sub.6 -alkanesulfonylamino, aminosulfonyl, aminosulfonyl which contains one or two C.sub.1 -C.sub.6 -alkyl radicals, C.sub.1 -C.sub.6 -alkoxysulfonyl (--SO.sub.2 --O--C.sub.1 --C.sub.6 -alkyl), sulfo (--SO.sub.3 H) or C.sub.1 -C.sub.6 -alkanesulfonyl and two of these groups can be the methylenedioxy group and X is the equivalent of a physiologically compatible anion, as well as optionally their salts with physiologically compatible cations and anions and process of their production.

    摘要翻译: 描述了通式如下的(1-苯乙二胺) - 铂(II) - 复合物:其中基团R 1,R 2,R 3和R 4相同或不同,为氢,C 1 -C 6 - 烷基 ,苄基或苯基乙基,B是噻吩基,吲哚基,咪唑基或被基团R5,R6,R7相同或不同并且为氢的卤素取代的苯基,卤素 ,三卤代甲基,C 1 -C 6烷基,羟基,C 1 -C 6 - 烷氧基,苯氧基,苄氧基,C 1 -C 6 - 烷酰氧基,苯甲酰氧基,C 1 -C 6烷基磺酰氧基,羧基,C 1 -C 6烷氧基,氰基,氨基羰基,氨基羰基 含有一个或两个C 1 -C 6烷基,C 1 -C 6烷基羰基,硝基,氨基,C 1 -C 6烷基氨基,二-C 1 -C 6烷基氨基,(C 1 -C 6烷基)3 N +,C 1 -C 6烷酰基氨基, 含有一个或两个C 1 -C 6烷基的C 1 -C 6烷基-C 1 -C 6烷酰基氨基,C 1 -C 6烷基磺酰基氨基,C 1 -C 6烷基-C 1 -C 6烷基磺酰基氨基,氨基磺酰基,氨基磺酰基,C 1 -C 6烷氧基磺酰基 (-SO 2 -O-C 1 -C 6-a 烷基),磺基(-SO 3 H)或C 1 -C 6 - 烷基磺酰基,并且这些基团中的两个可以是亚甲二氧基,X是生理上相容的阴离子的当量,以及任选的与生理上相容的阳离子和阴离子的盐以及 他们的生产。